169342 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors Erythropoetin
METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE
#2USE OF THE BASIC FORM OF RECOMBINANT HUMAN ERYTHROPOIETIN IN THE TREATMENT OF A PATIENTS WITH SPINOCEREBELLAR ATAXIA WITH CAG REPEAT MUTATIONS
#3Antibodies to human erythroferrone and uses thereof
#4Use of Antibodies to TIMP-2 for the Improvement of Renal Function
#5SIGNAL BIOMARKERS
#6Method for the early detection of acute kidney injury in critical patients, using fibroblast growth factor 23, klotho and erythropoietin as biomarkers
#7Antibodies to human erythroferrone and uses thereof
#8Methods and compositions related to modulators of eukaryotic cells
#9METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF STROKE OR OTHER CEREBRAL INJURY
#10NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE
#11METHODS FOR TREATING A NEUROLOGICAL DISORDER IN A SUBJECT USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) PROYL HYDROXYLASE
#12TRAUMATIC BRAIN INJURY TREATMENT AND PREVENTION USING CYCLIC PRESSURE THERAPY
#13PROTEIN FORMULATIONS
#14Signal biomarkers
#15Methods and compositions related to modulators of eukaryotic cells
#16Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
#17METHODS FOR ASCERTAINING THE HISTORY OF HEMATOLOGICAL CONDITIONS OF A HUMAN FROM A SINGLE BLOOD SAMPLE
#18Erythropoietin receptor modified electrode and its preparation method and application
#19HOST CELLS COMPRISING ALPHA 1, 2 MANNOSIDASE AND CULTURE METHODS THEREOF
#20HOMOGENOUS AND FULLY GLYCOSYLATED HUMAN ERYTHROPOIETIN
#21Glycoprotein Analysis Kit and Use Thereof
#22Host cells and culture methods
#23NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE
#24Methods for improving kidney function
#25Signal biomarkers
#26IN-PROCESS CONTROL IN A METHOD FOR PRODUCING EPO
#27OPTIMIZING ERYTHROPOIETIN THERAPY
#28Method for measuring inhibitory activity on ligand-receptor binding
#29Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
#30Stabilization of hypoxia inducible factor (HIF) alpha
#31Host cells comprising alpha 1,2 mannosidase and culture methods thereof
#32Small Molecule Mimetics of Erythropoietin
#33Determination of Isoerythropoietins
#34Tissue protective erythropoietin receptor (NEPOR) and methods of use
#35Small Molecule Mimetics of Erythropoietin
#36Method for screening substances capable of promoting oligomerization of receptor protein molecules
#37Host cells comprising alpha 1,2 mannosidase and culture methods thereof
#38Stabilization of hypoxia inducible factor (HIF) alpha
#39Stabilization of hypoxia inducible factor (HIF) alpha
#40Stabilization of hypoxia inducible factor (HIF) alpha
#41Methods of increasing endogenous erythropoietin (EPO)
#42Method for screening substances capable of promoting oligomerization of receptor protein molecules
#43Methods of increasing endogenous erythropoietin (EPO)
#44Methods of increasing endogenous erythropoietin (EPO)
#45Small molecule mimetics of erythropoietin
#46Erythropoietin and erythropoietin receptor expression in human cancer
#47Methods and compositions for modulating erythropoietin expression